Literature DB >> 14673173

Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation.

Yuhong Shen1, Karni Schlessinger, Xuejun Zhu, Eric Meffre, Fred Quimby, David E Levy, J E Darnell.   

Abstract

A large number of extracellular polypeptides bound to their cognate receptors activate the transcription factor STAT3 by phosphorylation of tyrosine 705. Supplemental activation occurs when serine 727 is also phosphorylated. STAT3 deletion in mice leads to embryonic lethality. We have produced mice with alanine substituted for serine 727 in STAT3 (the SA allele) to examine the function of serine 727 phosphorylation in vivo. Embryonic fibroblasts from SA/SA mice had approximately 50% of the transcriptional response of wild-type cells. However, SA/SA mice were viable and grossly normal. STAT3 wild-type/null (+/-) animals were also normal and were interbred with SA/SA mice to study SA/- mice. The SA/- mice progressed through gestation, showing 10 to 15% reduced birth weight, three-fourths died soon after birth, and the SA/- survivors reached only 50 to 60% of normal size at 1 week of age. The lethality and decreased growth were accompanied by altered insulin-like growth factor 1 (IGF-1) levels in serum, establishing a role for the STAT3 serine phosphorylation acting through IGF-1 in embryonic and perinatal growth. The SA/- survivors have decreased thymocyte number associated with increased apoptosis, but unexpectedly normal STAT3-dependent liver acute phase response. These animals offer the opportunity to study defined reductions in the transcriptional capacity of a widely used signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14673173      PMCID: PMC303338          DOI: 10.1128/MCB.24.1.407-419.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

Authors:  M Lakso; J G Pichel; J R Gorman; B Sauer; Y Okamoto; E Lee; F W Alt; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.

Authors:  G B Udy; R P Towers; R G Snell; R J Wilkins; S H Park; P A Ram; D J Waxman; H W Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Genetics of mouse growth.

Authors:  A Efstratiadis
Journal:  Int J Dev Biol       Date:  1998       Impact factor: 2.203

4.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

Authors:  K Takeda; K Noguchi; W Shi; T Tanaka; M Matsumoto; N Yoshida; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses.

Authors:  S J Rodig; M A Meraz; J M White; P A Lampe; J K Riley; C D Arthur; K L King; K C Sheehan; L Yin; D Pennica; E M Johnson; R D Schreiber
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

6.  Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice.

Authors:  T Alonzi; E Fattori; M Cappelletti; G Ciliberto; V Poli
Journal:  Cytokine       Date:  1998-01       Impact factor: 3.861

7.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.

Authors:  K Takeda; T Kaisho; N Yoshida; J Takeda; T Kishimoto; S Akira
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

8.  Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation.

Authors:  J J Zhang; Y Zhao; B T Chait; W W Lathem; M Ritzi; R Knippers; J E Darnell
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.

Authors:  S Teglund; C McKay; E Schuetz; J M van Deursen; D Stravopodis; D Wang; M Brown; S Bodner; G Grosveld; J N Ihle
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

10.  Defective inflammatory response in interleukin 6-deficient mice.

Authors:  E Fattori; M Cappelletti; P Costa; C Sellitto; L Cantoni; M Carelli; R Faggioni; G Fantuzzi; P Ghezzi; V Poli
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  81 in total

1.  Cytoskeletal rearrangement and Src and PI-3K-dependent Akt activation control GABA(B)R-mediated chemotaxis.

Authors:  Madhavi J Rane; Jon B Klein; Michelle T Barati; Janice Scherzer; Rui Wu
Journal:  Cell Signal       Date:  2015-02-26       Impact factor: 4.315

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing.

Authors:  Yi Wen; W Haung Yu; Bryan Maloney; Jason Bailey; Junrong Ma; Isabelle Marié; Thomas Maurin; Lili Wang; Helen Figueroa; Mathieu Herman; Pavan Krishnamurthy; Li Liu; Emmanuel Planel; Lit-Fui Lau; Debomoy K Lahiri; Karen Duff
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

Review 4.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

5.  Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation.

Authors:  Jutong Si; Steven J Collins
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

6.  Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation.

Authors:  Victoria A Newton; Nicole M Ramocki; Brooks P Scull; James G Simmons; Kirk McNaughton; P Kay Lund
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

7.  Reduction of Stat3 activity attenuates HIV-induced kidney injury.

Authors:  Xiaobei Feng; Ting-Chi Lu; Peter Y Chuang; Wei Fang; Krishna Ratnam; Huabao Xiong; Xinshou Ouyang; Yuhong Shen; David E Levy; Deborah Hyink; Mary Klotman; Vivette D'Agati; Ravi Iyengar; Paul E Klotman; John C He
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

8.  Crif1 is a novel transcriptional coactivator of STAT3.

Authors:  Min-chul Kwon; Bon-Kyoung Koo; Jin-Sook Moon; Yoon-Young Kim; Ki Cheol Park; Nam-Shik Kim; Mi Yi Kwon; Myung-Phil Kong; Ki-Jun Yoon; Sun-Kyoung Im; Jaewang Ghim; Yong-Mahn Han; Sung Key Jang; Minho Shong; Young-Yun Kong
Journal:  EMBO J       Date:  2008-01-17       Impact factor: 11.598

9.  A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3.

Authors:  Daniel J Garama; Tiffany J Harris; Christine L White; Fernando J Rossello; Maher Abdul-Hay; Daniel J Gough; David E Levy
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

10.  LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model.

Authors:  B Fuh; M Sobo; L Cen; D Josiah; B Hutzen; K Cisek; D Bhasin; N Regan; L Lin; C Chan; H Caldas; S DeAngelis; C Li; P-K Li; J Lin
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.